A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines

Author： Chay C.H. Cooper C.R. Gendernalik J.D. Dhanasekaran S.M. Chinnaiyan A.M. Rubin M.A. Schmaier A.H. Pienta K.J.

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.60, Iss.5, 2002-11, pp. : 760-765

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High expression of the Met receptor in prostate cancer metastasis to bone

By Knudsen B.S. Gmyrek G.A. Inra J. Scherr D.S. Vaughan E.D. Nanus D.M. Kattan M.W. Gerald W.L. Vande Woude G.F.

Urology, Vol. 60, Iss. 6, 2002-12 ,pp. : 1113-1117

Elsevier

Access to resources Recommend Favorite

Expression pattern of the ADAMTS proteinases in human prostate cancer cell lines

By Chandrasekharan S. Hamdy F.C. Holen I. Cross N. Buttle D.J.

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 60-60

Elsevier

Access to resources Recommend Favorite

Specific T Cell Recognition of Peptides Derived from Prostate-specific Antigen in Patients with Prostate Cancer

By Alexander R.B. Brady F. Leffell M.S. Tsai V. Celis E.

Urology, Vol. 51, Iss. 1, 1998-01 ,pp. : 150-157

Elsevier

Access to resources Recommend Favorite

Expression of the androgen receptor coactivator Bag1 is upregulated in prostate cancer

By Klocker H. Rogatsch H. Culig Z. Bartsch G. Knezevic N. Liubov S. Cato A.B.C.

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 84-84

Elsevier

Access to resources Recommend Favorite

Dual 5 -reductase inhibitor, dutasteride, inhibits androgen action, cell growth/viability in prostate cancer cell lines

By Lazier C. Thomas L. Douglas R. Schmidt L. Tindall D.

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 37-37

Elsevier

Access to resources Recommend Favorite